Goelzer Investment Management Has Raised Dollar Tree (DLTR) Holding; Pura Vida Investments Raised Its Alexion Pharmaceuticals (ALXN) Holding

October 6, 2017 - By Marguerite Chambers

Goelzer Investment Management Inc increased Dollar Tree Inc (DLTR) stake by 29.83% reported in 2017Q2 SEC filing. Goelzer Investment Management Inc acquired 7,890 shares as Dollar Tree Inc (DLTR)’s stock declined 0.40%. The Goelzer Investment Management Inc holds 34,343 shares with $2.40 million value, up from 26,453 last quarter. Dollar Tree Inc now has $21.18 billion valuation. The stock increased 0.30% or $0.27 during the last trading session, reaching $89.42. About 2.52 million shares traded. Dollar Tree, Inc. (NASDAQ:DLTR) has risen 3.60% since October 6, 2016 and is uptrending. It has underperformed by 13.10% the S&P500.

Pura Vida Investments Llc increased Alexion Pharmaceuticals Inc (ALXN) stake by 30.54% reported in 2017Q2 SEC filing. Pura Vida Investments Llc acquired 20,612 shares as Alexion Pharmaceuticals Inc (ALXN)’s stock declined 11.63%. The Pura Vida Investments Llc holds 88,112 shares with $10.72M value, up from 67,500 last quarter. Alexion Pharmaceuticals Inc now has $31.54 billion valuation. The stock decreased 1.73% or $2.49 during the last trading session, reaching $141.3. About 1.10 million shares traded. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has declined 18.12% since October 6, 2016 and is downtrending. It has underperformed by 34.82% the S&P500.

Goelzer Investment Management Inc decreased Maxim Integrated Prods Inc (NASDAQ:MXIM) stake by 11,415 shares to 121,843 valued at $5.47 million in 2017Q2. It also reduced Csx Corp (NYSE:CSX) stake by 41,990 shares and now owns 9,451 shares. Dbx Etf Tr (DBEF) was reduced too.

Since June 15, 2017, it had 2 buys, and 0 selling transactions for $600,695 activity. Lewis Lemuel E had bought 3,475 shares worth $248,295 on Thursday, June 15. Another trade for 5,000 shares valued at $352,400 was made by Hall Conrad M. on Friday, June 16.

Among 29 analysts covering Dollar Tree Inc. (NASDAQ:DLTR), 18 have Buy rating, 1 Sell and 10 Hold. Therefore 62% are positive. Dollar Tree Inc. had 72 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of Dollar Tree, Inc. (NASDAQ:DLTR) earned “Market Perform” rating by BMO Capital Markets on Tuesday, May 31. The firm has “Buy” rating given on Friday, September 11 by Canaccord Genuity. The firm has “Neutral” rating by Citigroup given on Monday, June 6. Barclays Capital initiated the stock with “Equal-Weight” rating in Friday, September 23 report. The firm has “Underweight” rating by Atlantic Securities given on Tuesday, September 27. The rating was downgraded by Raymond James to “Market Perform” on Wednesday, March 2. The company was maintained on Thursday, July 27 by RBC Capital Markets. Buckingham Research initiated the stock with “Buy” rating in Tuesday, February 23 report. Morgan Stanley maintained the stock with “Equal-Weight” rating in Friday, August 25 report. The company was maintained on Tuesday, October 3 by KeyBanc Capital Markets.

Investors sentiment increased to 1.24 in 2017 Q2. Its up 0.34, from 0.9 in 2017Q1. It improved, as 51 investors sold DLTR shares while 170 reduced holdings. 75 funds opened positions while 200 raised stakes. 210.13 million shares or 1.98% less from 214.37 million shares in 2017Q1 were reported. Nokota Mngmt Limited Partnership invested in 1.39M shares. Stelliam Mgmt Limited Partnership holds 3.01% of its portfolio in Dollar Tree, Inc. (NASDAQ:DLTR) for 1.34 million shares. Cibc owns 51,021 shares for 0.04% of their portfolio. Ing Groep Nv stated it has 52,135 shares. State Of Wisconsin Invest Board holds 0.07% or 324,921 shares in its portfolio. Department Mb Comml Bank N A owns 1,210 shares for 0.01% of their portfolio. Frontier Management Llc holds 0.31% of its portfolio in Dollar Tree, Inc. (NASDAQ:DLTR) for 608,627 shares. 2.51 million are held by Invesco Ltd. Cornerstone Mgmt Ltd Co owns 40,872 shares for 0.02% of their portfolio. Fiduciary Trust reported 0.08% of its portfolio in Dollar Tree, Inc. (NASDAQ:DLTR). Century Companies has invested 0.2% in Dollar Tree, Inc. (NASDAQ:DLTR). Boston Family Office Limited Liability holds 0.79% or 95,687 shares in its portfolio. Alexandria Limited Liability Corp holds 0.01% of its portfolio in Dollar Tree, Inc. (NASDAQ:DLTR) for 402 shares. Jpmorgan Chase has invested 0.01% in Dollar Tree, Inc. (NASDAQ:DLTR). Blackrock owns 15.90 million shares or 0.06% of their US portfolio.

Since June 14, 2017, it had 4 insider purchases, and 1 insider sale for $235.75 million activity. On Wednesday, June 14 BAKER BROS. ADVISORS LP bought $77.53 million worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) or 660,779 shares. The insider HANTSON LUDWIG bought $1.17M. On Thursday, June 15 the insider PARVEN ALVIN S sold $97,511. 2,000 shares were bought by COUGHLIN CHRISTOPHER J, worth $234,200.

Investors sentiment increased to 1.37 in 2017 Q2. Its up 0.23, from 1.14 in 2017Q1. It improved, as 55 investors sold ALXN shares while 146 reduced holdings. 72 funds opened positions while 203 raised stakes. 208.01 million shares or 0.31% less from 208.67 million shares in 2017Q1 were reported. City Company has invested 0% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Tarbox Family Office holds 0% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 20 shares. Moreover, Fmr Ltd Liability has 0.32% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). D E Shaw & Com Inc reported 289,584 shares stake. Balyasny Asset Management Limited Com has invested 0.09% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). State Of New Jersey Common Pension Fund D owns 0.09% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 180,000 shares. Adage Cap Prtnrs Lc invested 0.1% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). 130 are held by Whittier Company. Connor Clark Lunn Investment Mgmt Ltd owns 0.03% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 43,675 shares. State Of Tennessee Treasury Department stated it has 0.22% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). State Of Wisconsin Investment Board accumulated 265,316 shares. Ballentine Prtn Ltd holds 0.02% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) or 1,955 shares. Manufacturers Life Insurance The invested 0.04% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Raymond James invested in 122,925 shares or 0.03% of the stock. Voya Investment Management Ltd Com holds 86,428 shares or 0.02% of its portfolio.

Among 27 analysts covering Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), 21 have Buy rating, 0 Sell and 6 Hold. Therefore 78% are positive. Alexion Pharmaceuticals Inc. had 78 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Citigroup given on Thursday, February 25. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) earned “Buy” rating by Stifel Nicolaus on Friday, December 11. JP Morgan upgraded Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) on Tuesday, September 5 to “Overweight” rating. On Thursday, January 7 the stock rating was initiated by Suntrust Robinson with “Buy”. On Friday, October 28 the stock rating was upgraded by Goldman Sachs to “Buy”. Credit Suisse upgraded the shares of ALXN in report on Monday, July 11 to “Outperform” rating. Citigroup upgraded the stock to “Buy” rating in Monday, June 27 report. The rating was maintained by Leerink Swann on Wednesday, September 13 with “Buy”. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has “Hold” rating given on Wednesday, June 14 by Oppenheimer. The firm has “Hold” rating by Jefferies given on Wednesday, June 7.